Clearline Capital’s Seagen Inc. Common Stock SGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding SGEN
BBA
Clearline Capital's SGEN Position: Q1 2023 in Review
Clearline Capital sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 11,295 shares — an estimated $1.45M sold.
Clearline Capital first reported a position in SGEN in Q3 2022 and held it in 2 quarters. The position peaked at $1.54M in Q3 2022. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.
- Clearline Capital reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Clearline Capital sold 11,295 Seagen Inc. Common Stock shares in Q1 2023, an estimated $1.45M.
- Clearline Capital first reported a position in Seagen Inc. Common Stock in Q3 2022 and held it in 2 quarters.
- Clearline Capital's Seagen Inc. Common Stock position peaked at $1.54M in Q3 2022.
- 575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.
Based on Clearline Capital's 13F filing for Q1 2023, filed 15 May 2023.